Albemarle (ALB) – Investment Analysts’ Weekly Ratings Changes

Albemarle (NYSE: ALB) recently received a number of ratings updates from brokerages and research firms:

• 11/9/2026 – Albemarle had its price target lowered by Scotiabank from $190.00 to $165.00. They now have a “sector outperform” rating on the stock.
• 11/9/2026 – Albemarle was upgraded by Zacks Research from “strong sell” to “hold”.
• 11/9/2026 – Albemarle had its price target lowered by UBS Group from $150.00 to $137.00. They now have a “buy” rating on the stock.
• 11/9/2026 – Albemarle had its price target raised by Citigroup from $125.00 to $140.00. They now have a “buy” rating on the stock.
• 11/9/2026 – Albemarle had its price target lowered by Morgan Stanley from $161.00 to $105.00. They now have an “equal weight” rating on the stock.
• 11/7/2026 – Albemarle was downgraded by Wall Street Zen from “buy” to “hold”.
• 11/6/2026 – Albemarle had its price target lowered by Royal Bank Of Canada from $129.00 to $119.00. They now have an “outperform” rating on the stock.
• 11/6/2026 – Albemarle had its “buy” rating reaffirmed by Truist Financial. They now have a $170.00 price target on the stock, down from $185.00.
• 11/6/2026 – Albemarle had its price target lowered by Barclays from $109.00 to $95.00. They now have an “equal weight” rating on the stock.
• 11/4/2026 – Albemarle was upgraded by Weiss Ratings from “sell (d+)” to “hold (c-)”.
• 10/23/2026 – Albemarle was downgraded by Weiss Ratings from “hold (c-)” to “sell (d+)”.
• 10/22/2026 – Albemarle had its price target lowered by Citigroup from $175.00 to $125.00. They now have a “buy” rating on the stock.
• 10/20/2026 – Albemarle had its price target lowered by Truist Financial from $225.00 to $185.00. They now have a “buy” rating on the stock.
• 10/15/2026 – Albemarle had its price target lowered by Royal Bank Of Canada from $157.00 to $129.00. They now have an “outperform” rating on the stock.
• 10/14/2026 – Albemarle was upgraded by Mizuho from “neutral” to “outperform”. They now have a $130.00 price target on the stock.
• 10/12/2026 – Albemarle is now covered by Barclays. They set an “equal weight” rating and a $109.00 price target on the stock.
• 10/12/2026 – Albemarle was upgraded by Barclays to “hold”.
• 10/10/2026 – Albemarle was upgraded by Wall Street Zen from “hold” to “buy”.
• 10/9/2026 – Albemarle was downgraded by Zacks Research from “hold” to “strong sell”.
• 10/8/2026 – Albemarle was upgraded by Weiss Ratings from “sell (d+)” to “hold (c-)”.
• 10/7/2026 – Albemarle had its price target lowered by Argus from $230.00 to $135.00. They now have a “buy” rating on the stock.
• 10/6/2026 – Albemarle had its “outperform” rating reaffirmed by BMO Capital Markets. They now have a $175.00 price target on the stock.
• 10/5/2026 – Albemarle had its price target lowered by UBS Group from $175.00 to $150.00. They now have a “buy” rating on the stock.
• 10/1/2026 – Albemarle had its price target lowered by Mizuho from $140.00 to $130.00. They now have a “neutral” rating on the stock.
• 9/18/2026 – Albemarle had its price target lowered by Mizuho from $160.00 to $140.00. They now have a “neutral” rating on the stock.

Albemarle Stock Up 2.2%

NYSE ALB traded up $2.08 on Wednesday, reaching $97.00. The company had a trading volume of 211,679 shares, compared to its average volume of 2,462,756. The company has a quick ratio of 1.57, a current ratio of 2.34 and a debt-to-equity ratio of 0.21. The company’s fifty day moving average is $106.02 and its 200 day moving average is $147.00. Albemarle Corporation has a 52-week low of $89.77 and a 52-week high of $221.00. The stock has a market capitalization of $11.45 billion, a P/E ratio of 23.43, a P/E/G ratio of 0.61 and a beta of 1.34.

Albemarle (NYSE:ALB) last issued its quarterly earnings data on Wednesday, November 4th. The specialty chemicals company reported $2.58 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.53 by $0.05. Albemarle had a net margin of 10.40% and a return on equity of 14.91%. The business had revenue of $1.55 billion during the quarter, compared to the consensus estimate of $1.52 billion. During the same period in the prior year, the firm posted ($0.19) EPS. The firm’s quarterly revenue was up 18.8% compared to the same quarter last year. Sell-side analysts anticipate that Albemarle Corporation will post 10.84 earnings per share for the current fiscal year.

Albemarle Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, January 4th. Investors of record on Friday, December 18th will be paid a dividend of $0.41 per share. This represents a $1.64 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date is Friday, December 18th. Albemarle’s dividend payout ratio is presently 39.61%.

Albemarle Corporation is a specialty chemicals company that produces lithium, bromine and refining catalysts. Its products serve industries including energy storage, transportation, electronics, petroleum refining and pharmaceuticals. The company supplies lithium compounds used in rechargeable batteries and other applications. It also makes bromine-based products for uses such as flame retardants and water treatment, along with catalysts used in refining petroleum. Albemarle traces its history to 1887 and is headquartered in Charlotte, North Carolina.